Here is the talk and presentation I gave at the 2012 ANZICS CTG meeting in Noosa about a planned trial called ALISAH II. It's a phase III clinical trial investigating concentrated albumin to treat patients with subarachnoid haemorrhage. It currently in the planning phase with a grant application pending.